The mechanism of lovastatin in suppressing the proliferation of esophageal squamous cell carcinoma based on proteomics
These results demonstrate the huge potential of lovastatin as an RAB38, RAB27A inhibitor in esophageal cancer chemotherapy and chemoprevention.
Authors
- Yang Fu (ORCID: https://orcid.org/0000-0002-4749-4605)
- Li Zhu (ORCID: https://orcid.org/0000-0001-5249-6536)
- Feng Peng (ORCID: https://orcid.org/0000-0002-1142-9377)
- Jiang Fan (ORCID: https://orcid.org/0000-0001-6206-5414)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai First People's Hospital (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- The Journal of Gene Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/jgm.3722
- Citations
- 3
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.86
Funders
- Wu Jieping Medical Foundation